Evidence map›Paper›PMID 27154461›Full record

ReviewBMC ophthalmology2016

Worldwide Argus II implantation: recommendations to optimize patient outcomes.

Devon H Ghodasra, Adrienne Chen, J Fernando Arevalo, David G Birch, Kari Branham, Brian Coley, Gislin Dagnelie, Eugene de Juan, Robert G Devenyi, Jessy D Dorn and 22 more

Erratum issuedOpen access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in BMC ophthalmology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Gene-agnostic approaches to treating inherited retinal degenerations.Frontiers in cell and developmental biology · 2023
    Review
  10. Article
  11. Article
  12. One-Year Anatomical and Functional Outcomes of the Argus II Implantation in Korean Patients with Late-Stage Retinitis Pigmentosa: A Prospective Case Series Study.Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Medical and Surgical Applications for the Suprachoroidal Space.International ophthalmology clinics · 2019
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 19 institutions in 4 countries.

Devon H GhodasraKellogg Eye Center, University of Michigan, Ann Arbor, MI, USA.
Adrienne ChenKellogg Eye Center, University of Michigan, Ann Arbor, MI, USA.
J Fernando ArevaloWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
David G BirchRetina Foundation of the Southwest, Dallas, TX, USA.
Kari BranhamKellogg Eye Center, University of Michigan, Ann Arbor, MI, USA.
Brian ColeySecond Sight Medical Products, Inc., Sylmar, CA, USA.
Gislin DagnelieWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Eugene de JuanUniversity of California, San Francisco, San Francisco, CA, USA.
Robert G DevenyiThe University of Toronto, Toronto, Canada.
Jessy D DornSecond Sight Medical Products, Inc., Sylmar, CA, USA.
Andy FisherFocal Point, Bristol, UK.
Duane R GeruschatWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ninel Z GregoriBascom Palmer Eye Institute, University of Miami, Miami, FL, USA.
Robert J GreenbergSecond Sight Medical Products, Inc., Sylmar, CA, USA.
Paul HahnDuke University Eye Center, Durham, NC, USA.
Allen C HoWills Eye Hospital, Philadelphia, PA, USA.
Ashley HowsonKellogg Eye Center, University of Michigan, Ann Arbor, MI, USA.
Suber S HuangRetina Center of Ohio, South Euclid, OH, USA.
Raymond IezziDepartment of Ophthalmology, Mayo Clinic, Rochester, MN, USA.
Naheed KhanKellogg Eye Center, University of Michigan, Ann Arbor, MI, USA.
Byron L LamBascom Palmer Eye Institute, University of Miami, Miami, FL, USA.
Jennifer I LimUniversity of Illinois at Chicago Eye and Ear Infirmary, Chicago, IL, USA.
Kirsten G LockeRetina Foundation of the Southwest, Dallas, TX, USA.
Michelle MarkowitzPrivate Practice, Toronto, Canada.
Anne-Marie RipleySecond Sight Medical Products, Inc., Sylmar, CA, USA.
Mark RankinCanadian National Institute for the Blind, Toronto, Canada.
Hannah SchimitzekDepartment of Ophthalmology, RWTH Aachen University, Aachen, Germany.
Fay TrippDuke University Eye Center, Durham, NC, USA.
James D WeilandDepartment of Ophthalmology, University of Southern California, Los Angeles, CA, USA.
Jiong YanEmory Eye Center, Atlanta, GA, USA.
David N ZacksKellogg Eye Center, University of Michigan, Ann Arbor, MI, USA.
K Thiran JayasunderaKellogg Eye Center, University of Michigan, Ann Arbor, MI, USA. thiran@umich.edu.
Second Sight Medical Products · USW.K. Kellogg Foundation · USUniversity of Michigan–Ann Arbor · USDuke University · USJohns Hopkins University · USRetina Foundation of the Southwest · USUniversity of Miami · USAt Bristol · GBCNIB Foundation · CAEmory Eye Center · USJohns Hopkins Medicine · USMayo Clinic in Arizona · USRWTH Aachen University · DEThe Retina Center · USUniversity of California, San Francisco · USUniversity of Illinois Chicago · USUniversity of Southern California · USUniversity of Toronto · CAWills Eye Hospital · US

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MCANANY, JAMES JASON · 1985 to 2025
$14.8M
MEASURES OF HUMAN RECEPTOR AND POST RECEPTOR ACTIVITYR01EY009076 · NEI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI BIRCH, DAVID G, HOOD, DONALD C. · 1991 to 2021
$8.3M
NEI NIH HHS P30 EY001792NEI NIH HHS R01 EY009076
6 · The paper itself

Abstract

backgroundA position paper based on the collective experiences of Argus II Retinal Prosthesis System investigators to review strategies to optimize outcomes in patients with retinitis pigmentosa undergoing retinal prosthesis implantation.

methodsRetinal surgeons, device programmers, and rehabilitation specialists from Europe, Canada, Middle East, and the United States were convened to the first international Argus II Investigator Meeting held in Ann Arbor, MI in March 2015. The recommendations from the collective experiences were collected. Factors associated with successful outcomes were determined.

resultsFactors leading to successful outcomes begin with appropriate patient selection, expectation counseling, and preoperative retinal assessment. Challenges to surgical implantation include presence of staphyloma and inadequate Tenon's capsule or conjunctiva. Modified surgical technique may reduce risks of complications such as hypotony and conjunctival erosion. Rehabilitation efforts and correlation with validated outcome measures following implantation are critical.

conclusionsBringing together Argus II investigators allowed the identification of strategies to optimize patient outcomes. Establishing an on-line collaborative network will foster coordinated research efforts to advance outcome assessment and rehabilitation strategies.

Indexed as

Electrodes, ImplantedVisual ProsthesisBlindnessHumansOutcome Assessment, Health CarePatient SelectionProsthesis ImplantationRetinitis Pigmentosa

Identifiers

PMID27154461
PMCPMC4858839
OpenAlexW2345822578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.